Immunotherapy: Open Access is an open access peer reviewed journal which ardent to promote and publish novel research findings and reviews of already published novel works. Immunotherapy: Open Access does this fast-track rapid peer review with the help of eminent reviewers and editors.

The editorial board formed with the eminent researches throughout the globe with maximum geographical distribution. All the editors are highly qualified as professors and research scientists. They will review under double blinded review process.

Immunotherapy is a treatment procedure which enhances or supress the body’s immune system to fight against a disease. Immunotherapies which enhance the immune response are called as activation immunotherapies and those which reduce or suppress the immune response are called as suppression immunotherapies. Immunotherapy is of many types but the major immunotherapies for cancer include Monoclonal antibodies, Cancer vaccines and Non-specific immunotherapies.

The Journal of immunotherapy covers a wide range of topics related to allergy immunotherapy, cancer immunotherapy, immunotherapy for Kidney failure, lung cancer immunotherapy, melanoma immunotherapy, prostate cancer immunotherapy, sublingual immunotherapy, immunotherapy for HIV, immunotherapy for autoimmune diseases and transplantation, biomarkers for cancer immunotherapy, drug delivery systems and drug interactions, novel immunotherapeutic agents and immunotherapeutics clinical trials for immunotherapy etc. The journal also covers immunotherapeutic products, regulatory and FDI guidelines for immunotherapeutics and immunotherapy for kidney failure.

Journal invites eminent researchers to join our editorial board. Journal is committed to ensuring high quality of research published. We believe that a dedicated and committed team of editors and reviewers make it possible to ensure the quality of the research papers. The overall standing of a journal is in a way, reflective of the quality of its Editor(s) and Editorial Board and its members.

 The essential criteria to become Editorial Board Members are as follows:

    Experience in the field with an academic degree.

    At least 20 publication records of articles and /or books related to the field of Cancer and Chemotherapy or in a specific research field.

    Proficiency in English language.

 The Roles of Editorial Board Member are to:

    Offer advice on journals’ policy and scope.

    Submit or solicit at least one article for the journal annually.

    Contribute and/or solicit Guest Edited thematic issues to the journal in a hot area (at least one thematic issue every two years).

    Peer-review of articles for the journal, which are in the area of expertise (2 to 3 times per year).

If you are interested in becoming our Editorial Board member, please submit the following information and a copy of your CV to [email protected]

We will respond to your inquiry shortly.

Media contact:

 Sarah Eve

Managing Editor

Immunotherapy: Open access

Whatsapp No:  +1-504-608-2390

Email: [email protected]